Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Eyenovia, Inc. - Common Stock (NQ:EYEN)

1.485 -0.185 (-11.08%)
Streaming Delayed Price Updated: 9:58 AM EDT, May 21, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Eyenovia, Inc. - Common Stock

Peraso Inc. (NASDAQ: PRSO): “The Convergence of Technical Momentum and Military Innovation” – More Stocks Inside
Via AB Newswire
Topics Artificial Intelligence
Exposures Artificial Intelligence Product Safety
NovaBay Pharmaceuticals and Eyenovia Commence Co-Promotion Activities
From NovaBay Pharmaceuticals, Inc.
Via Business Wire
NASDAQ:EYEN Investor Notice: Investigation over Potential Wrongdoing at Eyenovia, Inc.
San Diego, CA -- (SBWIRE) -- 10/11/2023 -- Certain directors of Eyenovia, Inc. are under investigation over potential breaches of fiduciary duties. 
Via SBWire
Glancy Prongay & Murray LLP Announces Investigation of Eyenovia, Inc. (EYEN)
From Glancy Prongay & Murray LLP
Via Business Wire
Eyenovia Expands Its US Manufacturing Capabilities
Via ACCESSWIRE
Eyenovia Inc. (NASDAQ: EYEN) Records 52-Week High Tuesday Morning
Via Investor Brand Network
Eyenovia, Inc. (NASDAQ:EYEN) Investor Notice: Investigation over Possible Securities Laws Violations
San Diego, CA -- (SBWIRE) -- 05/24/2023 -- An investigation was announced for investors of Eyenovia, Inc. (NASDAQ:EYEN) shares over potential securities laws violations by Eyenovia, Inc. 
Via SBWire
Glancy Prongay & Murray LLP Announces Investigation of Eyenovia, Inc. (EYEN)
From Glancy Prongay & Murray LLP
Via Business Wire
Eyenovia Showcases Microdose Array Print (MAP™) Technology at CES 2023 in Las Vegas
In the Digital Health and Startups category at the 2023 Consumer Electronics Show (CES), Eyenovia showcased its Microdose Array Print (MAP™) Technology, the first significant advancement in ocular drug... 
Via Newswire.com
Eyenovia Aims to Revolutionize Ophthalmology Devices With Microdose Array Print (MAP) Technology
The Microdose Array Print (MAP) Technology has shown potential in clinical trials, providing the possibility of more accurate ocular drug delivery than traditional eye droppers 
Via Newswire.com
Eyenovia's Novel Optejet® Dispenser Puts People's Eyes First
While traditional eye drop bottles require hand-eye coordination and deliver four to five times more medication than the human eye can hold, the Optejet® dispenser's human-centric design administers an... 
Via Newswire.com
Eyenovia to Participate in a Presbyopia Panel Discussion at Eyecelerator 2021
From Eyenovia, Inc.
Via Business Wire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.